Phibro Animal Health Corporation and Rejuvenate Bio Announce Agreement to Develop Gene Therapy for Mitral Valve Disease in Canines

Written By Noah Davidsohn
Noah Davidsohn
Previous

Rejuvenate Bio Announces Team Expansion with Appointments of Garrett Berry and Sophia Gee
Next

Rejuvenate Bio Raises Over $10M in Series A Funding for Gene Therapy Aging Treatment